Apellis Pharmaceuticals Inc at Citi BioPharma Conference (Virtual) - Fireside Chat Transcript
Okay. It looks like it's working well. Great. So welcome, everyone, to the Apellis fireside chat. I have Cedric Francois, CEO; and Tim Sullivan, CFO; and Adam Townsend, Head of Commercial. So welcome to all of you. And I think everyone knows me. I'm Yigal Nochomovitz, one of the biotech analysts at Citi. (Operator Instructions)
So with that, welcome, gentlemen. Thank you so much for participating in the panel.
Cedric, I think maybe just to start off, it would be great if you could just do a quick 3-, 4-minute intro just to help everyone get up to speed on what Apellis does, what is the mission of the company and what are the key milestones to expect coming up?
Thank you so much, Yigal. And thank you again for hosting us at this year's conference, different from last year, but very special nonetheless.
So for those of you not familiar with Apellis, we are a company focused on
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |